Drug Trial Radar · NCT06223958
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
Last checked: Nov 20, 2026Latest source record: Apr 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
344
Actual
Start
Jan 29, 2024
Primary completion
Apr 29, 2026
Study completion Sep 27, 2027
Sponsor
- Lead sponsor
- Ocular Therapeutix, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Fortrea; Duke University
- First posted
- Jan 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration
Conditions
- Neovascular Age-Related Macular Degeneration
Interventions
OTX-TKI (axitinib implant)Drug
Intravitreal Injection of OTX-TKI (axitinib implant)
AfliberceptDrug
Injection of 2mg (0.05mL) of aflibercept
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best corrected visual acuity (BCVA)Time frame: Up to 36 Weeks
Locations
108 sites in 3 countries. Site status is shown where the registry gives one.
Associated Retina Consultants - Gilbert
Gilbert, Arizona
Associated Retina Consultants - Phoenix
Phoenix, Arizona
Retinal Research Institute
Phoenix, Arizona
Retina Macula Institute of Arizona
Scottsdale, Arizona
CA CRC California Retina Consultants
Bakersfield, California
The Retina Partners - Encino
Encino, California
Retina Consultants of Orange County - Fullerton
Fullerton, California
Atlantis Eyecare
Huntington Beach, California
Lakeside Vision Center - Irvine
Irvine, California
Retina-Vitreous Associates Medical Group - Los Angeles
Los Angeles, California
CA RCMG Retinal Consultants Medical Group, Inc.
Modesto, California
Retina Sacramento MSO, LLC
Modesto, California
Kaiser Permanente Division of Research
Oakland, California
CA CRC California Retina Consultants
Oxnard, California
Stanford University School of Medicine, Byers Eye Institute
Palo Alto, California
Doheny Eye Center
Pasadena, California
AzulVision
Pasadena, California
Orange County Retina Medical Group
Santa Ana, California
California Retina Consultants (CRC) - Santa Barbara
Santa Barbara, California
Macula Retina Vitreous Center
Torrance, California
Bay Area Retina Associates, A Medical Group
Walnut Creek, California
Retina Consultants of Southern Colorado - Colorado Springs
Colorado Springs, Colorado
RSC Research, PLLC
Denver, Colorado
Colorado Retina Associates (CRA) - Lakewood
Lakewood, Colorado
Retina Group of New England, PC
Waterford, Connecticut
The Macula Center - Clearwater Office (Suncoast Retina Consultants, LLC)
Clearwater, Florida
Rand Eye Institute
Deerfield Beach, Florida
Speciality Retina Center
Deerfield Beach, Florida
Retina Group of Florida - Fort Lauderdale
Fort Lauderdale, Florida
Florida Retina Institute - Lake Mary
Lake Mary, Florida
Florida Retina Consultants - Lakeland
Lakeland, Florida
South Florida Retina Institute
Miami, Florida
Retina Specialty Institute - Pensacola
Pensacola, Florida
MedEye Associates - Miami
South Miami, Florida
Retina Vitreous Associates of Florida (RVA) - Saint Petersburg
St. Petersburg, Florida
Retina Vitreous Associates of Florida - Tampa
Tampa, Florida
Retina Associates of Florida LLC Tampa MacDill
Tampa, Florida
Southeast Retina Center, P.C. - Augusta
Augusta, Georgia
Illinois Eye and Ear Infirmary at UI Health UIC
Chicago, Illinois
Illinois Retina Associates, S.C. - Lincoln Park
Chicago, Illinois
Showing 40 of 108 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.